We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

688256:SSECambricon Technologies Corp. Ltd. Class A Analysis

Data as of 2026-08-26 - not real-time

CN¥1,010.48

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Cambricon Technologies Corporation Limited trades at ¥1,010.48, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Over a rolling month the price has lost 28.4%. With RSI at 40.3 the momentum picture is neutral, alongside a bearish MACD signal. Price has been bracketed by support at ¥950.00 and resistance at ¥1,213.00.
Valuation screens as overvalued: a P/E of 192.5 sits above the sector average of 34.9. Consensus targets land 66.1% above where the shares trade now. Revenue is growing at 75.8% on a 34.7% profit margin. The 0.15% dividend yield looks covered by current payout levels.
Risk scores 8 out of 10, which is high for this asset class. With 30-day volatility of 85.1%, a beta of 0.86 and a maximum drawdown of 39.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.

Top Market Events

Barron's1monCambricon Technologies Corp. Ltd. ACambricon Technologies Corp. Ltd. builds core processor chips for...Barron's3monCambricon Technologies Corp. Ltd. ACambricon Technologies Corp. Ltd. builds core processor chips for...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading below the 200-day average of 1013.52
  • MACD momentum is negative
  • 30-day price change of -28.4%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 192.5 versus sector average of 34.9
  • Trading below the 200-day average of 1013.52
  • Analyst targets imply +66.1% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 192.5 versus sector average of 34.9
  • Analyst targets imply +66.1% versus the current price
  • Profit margin of 34.7% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth75.80%
Profit Margin34.66%
P/E Ratio192.5
ROE32.78%
ROA13.52%
Debt/Equity0.14
P/B Ratio46.8
Op. Cash FlowCN¥-1098233856
Free Cash FlowCN¥-3145672448
Industry P/E34.9

Technical Analysis

TrendNeutral
RSI40.3
SupportCN¥950.00
ResistanceCN¥1,213.00
MA 20CN¥1,090.97
MA 50CN¥1,259.29
MA 200CN¥1,013.52
MACDBearish
VolumeDecreasing
Fear & Greed Index93.84

Valuation

Target PriceCN¥1,678.08
Upside/Downside66.07%
GradeOvervalued
TypeGrowth
Dividend Yield0.15%

Risk Assessment

Beta0.86
Volatility85.11%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.